Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 4Breast 4Thoracic 2Plasma cell 2Other hematologic neoplasm 2Genitourinary 2Gastrointestinal 2Sarcoma 1Other solid neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1

Conditions

Prostatic Neoplasms 1Frailty 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Geriatric Assessment × Gastrointestinal × 1 year × Clear all
NCT03894917 2026-01-08

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

The University of Texas Health Science Center at San Antonio

Recruiting
84 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06125145 2025-12-05

GAP

University of California, Davis

Phase NA Completed
30 enrolled
BreastGastrointestinalGenitourinary

Frailty, Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡